Silicone covered memory metal offers multi-use trial rods for lumbar fixation
Double Digit Revenue Growth across the United States, Europe and Asia-Pacific.
David Shulkin’s experience in running healthcare systems makes the appointment a strategic addition as ControlRad moves into a commercial phase.
Nanovis Expands the Range of Footprints for its Signature FortiCore Posterior Lumbar Interbody Fusion System
Complete PLIF size offering now includes 32mm, 28mm, 25mm, and 22mm.
MedTech Momentum Launches the “MT-7 Framework for Growth” to Help Medical Device Organizations Turn Digital Marketing into a Growth Engine
The “MT-7 Framework for Growth” is a tested formula developed to address the needs of MedTech Companies looking to leverage the power of the Internet and Social Media to generate revenues.
Most Medical Technology companies are in a conundrum when trying to achieve MedTech marketing success and growth. The old ways of pushing new technologies, with traditional sales & marketing strategies are gone, and the ever-evolving Internet revolution is not conducive to developing distribution networks and building personal relationships with physicians… so they say! The reality […]
OrthoDirectUSA® Launches a Revolutionary Franchise Opportunity for Surgeons that Guarantees to Reduce Healthcare Costs
ODUSA Franchise, LLC – An industry first alignment mechanism that equips surgeons to lead the process improvement activities that can lower medical device procurement costs by 50% – 80%.
BioVentrix Announces First Patient at Cardiovascular Institute of the South Successfully Treated in IDE Study of Revivent TC™ TransCatheter Ventricular Enhancement Treatment
San Ramon, Calif., and Houma, LA,, March 12, 2018 — BioVentrix, Inc., a pioneer of technologies and procedures for less invasive treatment of heart failure (HF), today announced successful treatment of the first patient at the Cardiovascular Institute of the South in the ALIVE pivotal clinical trial.
BioVentrix Achieves 2018 NUB Reimbursement Status 1 in Germany for Revivent TC™ TransCatheter Ventricular Enhancement System
San Ramon, Calif., February 06, 2018 — BioVentrix, Inc. a pioneer of technologies and procedures for less invasive treatment of heart failure (HF), today announced a significant reimbursement achievement. InEk, the German Institute for Hospital Remuneration, has reconfirmed the award of NUB Status 1 for the Revivent TC™ TransCatheter Ventricular Enhancement System.
Even though our main responsibility is to provide MedTech Organizations with cutting-edge Marketing strategies, we feel that is our duty to warn you about increased dangers and security threats in the digital world, when we see them. This article is addressing a growing threat… Phishing Scams!